C-Ray Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 175

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $100M

  • Investors
  • 11

C-Ray General Information

Description

Developer of radiopharmaceuticals designed to address unmet clinical needs in oncology. The company's technology utilizes proprietary conjugation and linker platforms to develop targeted alpha therapies and radioligand treatments, enabling oncology patients to access precision medicine that integrates tumor visualization with therapeutic destruction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 198, Haida Road
  • Wenjiang District
  • Chengdu, Sichuan 611130
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Number 198, Haida Road
  • Wenjiang District
  • Chengdu, Sichuan 611130
  • China
+86 028

C-Ray Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

C-Ray Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A1) 09-Sep-2024 $100M Completed Generating Revenue
3. Early Stage VC 28-May-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Aug-2022 $2M Completed Generating Revenue
1. Seed Round 30-Jul-2021 $2M $2M Completed Generating Revenue
To view C-Ray’s complete valuation and funding history, request access »

C-Ray Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

C-Ray Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
3Sbio Corporation Minority
GL Ventures Venture Capital Minority
Guanghua Kaiyuan Capital Asset Manager Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
MIC Capital Management UK LLP Asset Manager Minority
You’re viewing 5 of 11 investors. Get the full list »

C-Ray FAQs

  • When was C-Ray founded?

    C-Ray was founded in 2020.

  • Where is C-Ray headquartered?

    C-Ray is headquartered in Chengdu, China.

  • What is the size of C-Ray?

    C-Ray has 175 total employees.

  • What industry is C-Ray in?

    C-Ray’s primary industry is Drug Discovery.

  • Is C-Ray a private or public company?

    C-Ray is a Private company.

  • What is C-Ray’s current revenue?

    The current revenue for C-Ray is .

  • How much funding has C-Ray raised over time?

    C-Ray has raised $102M.

  • Who are C-Ray’s investors?

    3Sbio, GL Ventures, Guanghua Kaiyuan Capital, Hangzhou Tailong Venture Capital Partnership, and MIC Capital Management UK LLP are 5 of 11 investors who have invested in C-Ray.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process